A cost-minimization analysis of a new fixed-dose combination of dutasteride and tamsulosin compared to concomitant administration of both monotherapies for the treatment of symptomatic benign prostatic hyperplasia in Quebec, Canada
Abstract
Authors
A. Sayani A. Ismaila J. Posnett A. Walker B. Laroche J.C. Nickel Z. Su